Table 1 Clinical and Demographic Characteristics of Study Population
Characteristic | Median (25–75) / Frequency |
|---|---|
Age | 40.0 (31.0–56.3) |
Sex | |
 Male | 121 (71.2%) |
 Female | 49 (28.8%) |
History of previous UGIB | 65 (38.2%) |
Use of NSAIDs in previous one week | 7 (4.1%) |
Comorbidity | |
 Any Comorbidity | 106 (62.4%) |
 Cardiac Disease | 14 (8.2%) |
 Renal Insufficiency | 26 (15.3%) |
 Chronic Liver Disease | 52 (30.6%) |
 Encephalopathy | 14 (8.2%) |
 Malignancy | 16 (9.4%) |
 Hypertension | 13 (7.6%) |
 Diabetes Mellitus | 5 (2.9%) |
 HIV | 7 (4.1%) |
Smoking | 9 (5.3%) |
Alcohol use in previous one week | 22 (12.9%) |
Initial Vital Signs | |
 Systolic Blood Pressure (mmHg) | 113.5 (102.0–130.0) |
 Diastolic Blood Pressure (mmHg) | 63.0 (56.8–80.3) |
 Pulse Rate (beats/min) | 101.5 (86.0–108.3) |
 Respiratory Rate (breaths/min) | 20.0 (19.0–23.0) |
 Arterial Oxygen Saturation (%) | 100.0 (100.0–100.0) |
Initial Laboratory Data | |
 White Blood Count (k/μl) | 8.1 (4.6–12.4) |
 Hemoglobin (g/dL) | 6.2 (4.5–8.8) |
 Platelets (k/μl) | 178.5 (90.8–293.3) |
 Serum Creatinine (μmol/L) | 78.0 (63.5–150.5) |
 Serum BUN (g/dL) | 6.5 (3.3–12.6) |
 Serum ALT (U/L) | 23.0 (15.0–47.0) |
 Serum AST (U/L) | 36.0 (22.0–93.0) |
 Serum Total Bilirubin (μmol/L) | 12.7 (7.6–29.9) |
 Prothrombin Time (seconds) | 12.5 (11.2–14.1) |
 APTT (seconds) | 28.4 (25.2–32.8) |
 INR | 1.1 (1.0–1.3) |
Rockall Score | |
 Pre-Endoscopy | 3.0 (1.0–4.0) |
 Post-Endoscopy | 6.0 (4.0–7.0) |